At Upcoming September Investor Conferences Showcase – are live audio webcast and replays of these presentations on the Investors section of the company website, About Synta Pharmaceuticals Synta Pharmaceuticals Corp. Is a biopharmaceutical company developing small molecules on the discovery, development, and commercialization of expanding drugs and to improve the lives of patients with serious diseases such as cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical and preclinical-stage drug candidates with different mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities.

known , that the company will present at the following September investor conferences: Rodman & Renshaw Annual Global Investment Conference in New YorkMonday, September at 13.35 clock ThinkEquity 9th the Annual Growth Conference in New York Wednesday, September at 15.30 clock UBS Global Life Sciences Conference in New York Thursday, September 2012 at 03.30 clock Noble Financial Markets Life Sciences exhibition in Stamford, CTMonday, September 2012 at 13.00 clock .. Our reports provide fact-based news research and discoveries from around the world.In 1979 there were 28 deaths in all sorts of motor sport – into 2006 it was 37 . Into motorcycling, even though mortality rate have fallen, the rate of serious violations remains stubbornly high, the authors say.

Since 1995, laps been well declined steadily. High profile Formula One rate of almost 230 mph in 2004.

The authors argue, when improving safety should not be too restrictive, them to do must, however, have a certain influence.

Other articles from category "doctor":

Random articles